Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 41Leukemia, Myeloid, Acute 35Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Lymphoma, Non-Hodgkin 21Leukemia 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 17Myeloproliferative Disorders 13Multiple Myeloma 13Lymphoma 13Primary Myelofibrosis 12Hematologic Neoplasms 11Leukemia, Myelomonocytic, Juvenile 9Graft vs Host Disease 8Leukemia, Myelomonocytic, Chronic 7Lymphoma, Mantle-Cell 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myeloid, Accelerated Phase 5Congenital Abnormalities 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Leukemia, Neutrophilic, Chronic 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Blast Crisis 4Recurrence 3

Interventions

fludarabine phosphate 4Tacrolimus 4Mycophenolic Acid 4Cyclophosphamide 4Busulfan 4ponatinib 2fludarabine 2Whole-Body Irradiation 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mesna 2Melphalan 2Bone Marrow Transplantation 2thymoglobulin 1Lymphocyte Depletion 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immune System Diseases × thymoglobulin × Myeloid × Clear all
NCT02627573 2019-04-05

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

St. Petersburg State Pavlov Medical University

Phase 2 Terminated
32 enrolled
MyeloidOther hematologic neoplasm

Immune System Diseases, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡